MENU
JUN 2, 2021 Opens: 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Immuno-Oncology 2021

LabRoots is pleased to announce the inauguration of the Immuno-Oncology Virtual Event taking place on June 2, 2021. Immuno-Oncology is considered by some to be one of the most promising areas of research in the world of anti-cancer therapeutics. Learn from our experts how immunotherapies can work alone, together, or in combination with other treatments to fight cancer.

This year's event includes the following tracks and topics:

New Advancements in Immuno-Oncology

  • Cell Therapy Innovation
  • Checkpoint Inhibitors
  • Innate Immunity Considerations
  • Microbiome and Cancer
  • New Adaptive Immunity Considerations

Emerging Targets for Immuno-Oncology Therapy

  • Overcoming Obstacles in the Immunosuppressive Tumor Micro-environment
  • Molecular and Epigenetic Modulation
  • Cancer Immunotherapeutics and COVID-19
  • Novel Cell Therapy Targets and Engineering Strategies

Advancing Cancer Immunotherapies to the Clinic

  • Translational
  • Clinical

Recent breakthroughs in immuno-oncology research translate into a paradigm shift with regards to attacking advancing cancer. The benefits of immuno-oncology have resulted in long-lasting tumor regression where surgery, radiotherapy, chemotherapy, and targeted therapy proved less effective.

Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing.  This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.

Like the 2020 conference, this event will be produced on our robust platform, allowing you to watch, learn and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of LabRoots' most popular T-shirts.



Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2021 Immuno-Oncology Virtual Event. Submission is free. Submit your abstract here.

Continuing Education
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.

Use #LRimmuno to follow the conversation!


Speakers

Show Resources
You May Also Like
NOV 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
NOV 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Twelveyears ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event will again bring together clinician...
NOV 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Thirteen years ago Labroots launched a new system of learning for a global scientific audience. Now, the 2022 Clinical Diagnostics and Research Virtual Event will again bring together clinic...
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 7 th Ann...
SEP 06, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 06, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 8th Annu...
FEB 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
FEB 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is pleased to announce the 11th Annual Laboratory Animal Science Virtual Conference which will take place on February 10, 2022 . This is a premier online-only conference that will b...
APR 20, 2021 5:30 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
APR 20, 2021 5:30 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to announce our 9th Annual Genetics Virtual Week held on April 20-22, 2021! Genetics Virtual Week 2021 will offer a multi-day content-rich program combining stellar exper...
Agenda
  • Development of FGFR4 targeted Chimeric Antigen Receptors (CARs) for treatment of Rhabdomyosarcoma
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Development of FGFR4 targeted Chimeric Antigen Receptors (CARs) for treatment of Rhabdomyosarcoma
    Peter Sullivan, PhD
    Postdoctoral Fellow, Laboratory of Dr. Rimas Orentas, Seattle Children's Research Institute
  • Interrogating mechanisms of tumor-specific T cell exhaustion and activity in pancreatic ductal adenocarcinoma
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Interrogating mechanisms of tumor-specific T cell exhaustion and activity in pancreatic ductal adenocarcinoma
    Adam Burrack, M.S., Ph.D.
    Researcher, University of Minnesota, Center for Immunology
  • Using genetically engineered preclinical models to study T cell therapy against solid tumors
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Using genetically engineered preclinical models to study T cell therapy against solid tumors
    Leah Schmidt, PhD
    Postdoctoral Fellow, Fred Hutchinson Cancer Research Center
  • Emerging Targets for Immuno-Oncology Therapy
  • Interrogating mechanisms of tumor-specific T cell exhaustion and activity in pancreatic ductal adenocarcinoma
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Interrogating mechanisms of tumor-specific T cell exhaustion and activity in pancreatic ductal adenocarcinoma
    Adam Burrack, M.S., Ph.D.
    Researcher, University of Minnesota, Center for Immunology
  • Development of FGFR4 targeted Chimeric Antigen Receptors (CARs) for treatment of Rhabdomyosarcoma
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Development of FGFR4 targeted Chimeric Antigen Receptors (CARs) for treatment of Rhabdomyosarcoma
    Peter Sullivan, PhD
    Postdoctoral Fellow, Laboratory of Dr. Rimas Orentas, Seattle Children's Research Institute
  • New Advancements in Immuno-Oncology
  • Using genetically engineered preclinical models to study T cell therapy against solid tumors
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Using genetically engineered preclinical models to study T cell therapy against solid tumors
    Leah Schmidt, PhD
    Postdoctoral Fellow, Fred Hutchinson Cancer Research Center
Speakers

  • Adam Burrack, M.S., Ph.D.
    Researcher, University of Minnesota, Center for Immunology
    Biography

      Dr. Burrack obtained B.S. in Biology at the University of Wisconsin and a M.S. in Physiology at the University of Wisconsin-La Crosse. He went on to complete his PhD in Immunology at the University of Colorado – Anschutz Medical Campus. Family history of both type 1 diabetes and pancreatic cancer have greatly influenced Dr. Burrack’s scientific interests and research experiences. During graduate school, Dr. Burrack studied autoimmune diabetes recurrence and transplant recognition in a mouse model of type 1 diabetes in the laboratory of Ronald Gill. He then pursued post-doctoral at the University of Minnesota where he defined antigens that are recognized by alloreactive T cells direct transplant recognition. He also investigated how pancreatic beta cells respond to inflammation in the context of diabetes. With this background and specific interest in pancreatic diseases, he next joined the laboratory of Dr. Ingunn Stromnes at the University of Minnesota in the Center for Immunology. Over the past 3 years, he has developed novel mouse models of pancreatic cancer to interrogate the fate and functionality of tumor-specific T cells as well as mechanisms of immunotherapy resistance in the highly lethal disease, pancreatic cancer. This work has led to two first author publications in Cell Reports and Journal of Immunology. With these new models in hand, he is identifying novel strategies to enhance anti-tumor T cells in vivo to support pancreatic cancer eradication to inform clinical translation for pancreatic cancer patient treatment.

    • Leah Schmidt, PhD
      Postdoctoral Fellow, Fred Hutchinson Cancer Research Center
      Biography

        Leah Schmidt, PhD, is a postdoctoral fellow in the laboratory of Dr. Philip Greenberg at the Fred Hutchinson Cancer Research Center, and an AACR-AstraZeneca Immuno-oncology Research Fellow. Her research is focused on utilizing preclinical models for refining and improving engineered T cell therapies against solid tumors, including lung and pancreatic cancers. Prior to Fred Hutch, Dr. Schmidt completed her PhD thesis in the laboratory of Dr. Tyler Jacks at the Massachusetts Institute of Technology, where she studied the roles of natural killer cells in shaping anti-tumor immune responses in genetically engineered preclinical models. Her overarching scientific interest is uncovering strategies for improving patient outcomes by leveraging the immune system against human disease.

      • Peter Sullivan, PhD
        Postdoctoral Fellow, Laboratory of Dr. Rimas Orentas, Seattle Children's Research Institute
        Biography

          Dr. Peter Sullivan obtained his B.A. in Biology and Chemistry from Lake Forest College  and his Ph.D. from Cornell University, studying the molecular biology underlaying the neurodegenerative diseases ALS and FTLD. After obtaining his Ph.D., he moved into CD8 T cell biology to better understand how the immune system functions in health and disease with the goal of applying this knowledge to novel cellular therapies. He is currently a post-doctoral fellow working with Dr. Rimas Orentas at Seattle Children’s Research Institute. His research is focused on optimizing CAR T cell therapy for the treatment of pediatric solid tumors. Dr. Sullivan is excited to continue working in the emerging field of engineered cellular therapy.

        Sponsored by

        For information on becoming a sponsor or exhibitor, please click here.


        C.E. Credits

        The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


        Committee

        To download the Program Committee brochure here.


        • Tullia C. Bruno, PhD

          Tullia C. Bruno, PhD, is an Assistant Professor in the Department of Immunology at the University of Pittsburgh and a faculty member in the Tumor Microenvironment Center and the Cancer Immunology and Immunotherapy Program at the UPMC Hillman Cancer Center. She obtained her Ph.D ...

          See more See less
        • Shannon K. Oda, PhD

          Dr. Shannon Oda earned a Ph.D. in Immunology from the University of Colorado Anschutz Medical Campus and completed her postdoctoral training with Dr. Philip Greenberg at the Fred Hutchinson Cancer Research Center. She has received several awards, including the Evergreen Fund ...

          See more See less
        • Houssein Sater, MD

          Dr. Sater is a translational physician scientist (hematologist/oncologist) with special interest in immune therapy of cancer. He leads the Genitourinary Malignancies Branch efforts at understanding the role of cancer immunotherapy on the tumor (immune and non-immune) ...

          See more See less
        Help

        General Labroots Questions

        email support@labroots.com  

        Virtual Events and Webinars

        Supported Configurations

        • Operating System Internet Explorer Firefox Chrome Safari
          Vista IE8+ FF10+ Chrome15+
          Windows 7 IE8+ FF10+ Chrome15+
          Windows 8 IE10 FF10+ Chrome15+
          Mac OS X   FF10+ Chrome15+ Safari5.1+
        • Cookie settings: session cookies enabled
        • Browser configuration must have JavaScript enabled
        • Adobe Flash player 10.2 or later

        To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

        Internet Connection

        • A minimum of 100Kbps is recommended for audio-only events
        • A minimum of 300Kbps is recommended for speaker on-video events

        Computer Equipment

        • Screen Resolution: Minimum 1024x768
        • Video Card: 65,000 colors minimum
        • Sound card and speakers (or headphones) for hearing webcast in full format
        • Audio Card: 16-bit minimum
        • RAM: 512MB of free RAM

        Firewall Protocol

        • HTTP on port 80 or HTTPS on port 443
        • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
        • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

        Work-At-Home Attendees

        • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

        For A Seamless Experience

        When using a mobile device, FREE Mobile Apps are available:

        - For viewing Webinars:

        - For viewing Virtual Events

        Attendee Guide

        • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

        Virtual Event and Webinar Support:

        Continuing Education (CME/CE) Support

        Demographics

        Specialty

        Research And Development

        Cancer

        Research

        Disease

        Molecular Genetics

        Molecular Biology

        Cancer Research

        Health

        Immunology

        Cell

        Gene

        Drug Development

        Clinical Medicine

        Genetics

        Biotechnology

        Geography

        Asia37%

        North America27%

        Europe23%

        Africa8%

        South America3%

        Oceania1%

        Registration Source

        Labroots Registration (Also interested in)60%

        Website Visitors29%

        Website Banners3%

        Email Promotions3%

        WAVE Newsletter Promotion2%

        Social Media Promotions1%

        Client/Sponsor Promotions1%

        Job Title

        Student33%

        Research Scientist11%

        Educator/Faculty10%

        Executive7%

        Scientist7%

        Medical Laboratory Technician6%

        Facility/Department Manager6%

        Medical Doctor/Specialist5%

        Biologist3%

        Chemist3%

        Post Doc2%

        Clinical Laboratory Scientist2%

        Marketing/Sales2%

        QC/QA1%

        Pharmacist1%

        Lab Management1%

        Engineer1%

        Organization

        Academic Institution38%

        Biotech Company7%

        Clinical Laboratory7%

        Hospital6%

        Research Institute6%

        Government6%

        Medical School5%

        Pharmaceutical Company3%

        Government/public3%

        Life Science Company3%

        Distribution/sales2%

        Medical Center1%

        Consultant1%

        Veterinary School1%

        Other4%

        Posters

        CALL FOR POSTERS
        The deadline for electronic submission of your poster title, abstract and poster PDF is May 28th at 5:00pm.

        POSTER SUBMISSION GUIDELINES
        Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.

        SUBMIT YOUR ABSTRACT
        If you are interested in sponsoring a Poster for this virtual event and generate leads, the cost is $250 and you can submit the poster at advertise@labroots.com.

        All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by Labroots may display posters at this event.

        If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. Labroots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

        Questions? Email Posters@Labroots.com

        Labroots Policy

        Additional Authors
        Add another author
        Poster Title: 80 characters max
        Abstract: 500 characters max

        BACK
        CONTINUE

        Choose Additional Events for Submission

        BACK
        Loading Comments...
        Show Resources
        Event Countdown
        • 0 Days
        • 0 Hours
        • 0 Minutes
        • 0 Seconds
        Attendees
        • See more